XML 48 R23.htm IDEA: XBRL DOCUMENT v3.25.1
Summary of Significant Accounting Policies (Tables)
12 Months Ended
Dec. 31, 2024
Accounting Policies [Abstract]  
Schedule of Common Share Equivalents Included from Computation of Net Loss Per Share As the shares underlying these pre-funded warrants can be issued for little consideration (an exercise price per share equal to $0.001 per share), these shares are deemed to be issued for purposes of basic earnings per share.

 

 

Year Ended
December 31,

 

 

 

2024

 

 

2023

 

(In thousands, except share and per share data)

 

 

 

 

 

 

Net loss

 

$

(36,184

)

 

$

(116,537

)

Net loss per share, basic and diluted

 

$

(0.75

)

 

$

(4.73

)

Weighted-average number of common shares

 

 

48,543,787

 

 

 

24,619,197

 

Summary of Common Share Equivalents were excluded because the Inclusion is Anti-dilutive The following table provides a summary as of December 31, 2024 and 2023 common share equivalents that were excluded because their inclusion would have been anti-dilutive.

 

 

Year Ended
December 31,

 

 

 

2024

 

 

2023

 

 

 

 

 

Stock options outstanding and other equity awards

 

 

6,007,789

 

 

 

14,909,155

 

Common and preferred warrants outstanding

 

 

18,567,751

 

 

 

18,577,332

 

Total

 

 

24,575,540

 

 

 

33,486,487